Vedana Therapeutics | Biotech & Life Sciences | F4

Introducing F4 Champions, a new accelerator for founders at the earliest stage.F4 Champions for early-stage foundersEnrollment closesAugust 2Learn more

Team Portfolio Raise Champions Essays

F4/Vedana Therapeutics

Company Overview Team Backed By Recent Activity Similar Companies Startup DNA

Vedana Therapeutics

Vedana Therapeutics is developing innovative medicines to help patients achieve migraine freedom, focusing on next-generation therapies that target PACAP and other pathways beyond CGRP

United StatesFounded 202411-50 employees

Biotech & Life Sciences

Sector

Seed

Stage

2024

Founded

Biotechnology

Model

Biotech & Life Sciences

01Company Overview

Vedana Therapeutics is developing innovative medicines to help patients achieve migraine freedom, focusing on next-generation therapies that target PACAP and other pathways beyond CGRP.

02Team

AA

Anurag Agarwal

co-founder and ceo

03Backed By1 investor

Is this your company? Claim your profile

Startup Intelligence by F4F4 Research Engine

Canaan Partners

→

04Recent Activity

FROM Canaan Partners

Co-led Vedana Therapeutics' $46M Series A alongside Westlake BioPartners. Vedana is developing anti-PACAP therapies for migraine prevention.

INVESTMENT·canaan.com

JUN 16, 2026

05Similar Companies

SM

Slate Medicines

Biotech & Life Sciences

→

LT

Lys Therapeutics

Biotech & Life Sciences

→

SP

Satsuma Pharmaceuticals

Biotech & Life Sciences

→

EB

Evidence Bio

Biotech & Life Sciences

→

I

Invetx

Biotech & Life Sciences

→

06Startup DNA

signals

Sectors
Business Model
Technology

Quick Reference

Sector

Biotech & Life Sciences

Location

United States

Founded

2024

Team Size

11-50 employees

Tags

Biotech & Life Sciences